|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| EQUITY IN TRADING ACCOUNTS: | ||||||||||||||||||||
| Investments in U.S. Treasury notes – at fair value (amortized cost $13,648,839 and $11,038,872) | ||||||||||||||||||||
| Net unrealized appreciation on open futures and forward currency contracts | ||||||||||||||||||||
| Due from brokers, net | ||||||||||||||||||||
| Cash denominated in foreign currencies (cost $143,116 and $41,996) | ||||||||||||||||||||
| Total equity in trading accounts | ||||||||||||||||||||
| INVESTMENTS IN U.S. TREASURY NOTES – at fair value (amortized cost $35,601,793 and $40,931,124) | ||||||||||||||||||||
| CASH AND CASH EQUIVALENTS | ||||||||||||||||||||
| ACCRUED INTEREST RECEIVABLE | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND TRUST CAPITAL | ||||||||||||||||||||
| LIABILITIES: | ||||||||||||||||||||
| Net unrealized depreciation on open futures and forward currency contracts | ||||||||||||||||||||
| Due to Managing Owner | ||||||||||||||||||||
| Due to brokers, net | ||||||||||||||||||||
| Accrued management fees | ||||||||||||||||||||
| Accrued installment selling commissions | ||||||||||||||||||||
| Accrued trade execution and clearing costs | ||||||||||||||||||||
| Redemptions payable to Unitholders | ||||||||||||||||||||
| Redemptions payable to Managing Owner | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Cash overdraft denominated in foreign currencies (cost $510,849 and $40,880) | ||||||||||||||||||||
| Profit share accrued | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Trust capital | ||||||||||||||||||||
| Managing Owner Interest | ||||||||||||||||||||
| Series 1 | ||||||||||||||||||||
| Series 3 | ||||||||||||||||||||
| Series 4 | ||||||||||||||||||||
| Series 5 | ||||||||||||||||||||
| Total trust capital | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| NET ASSET VALUE PER UNIT OUTSTANDING: | ||||||||||||||||||||
| NET ASSET VALUE PER UNIT OUTSTANDING | ||||||||||||||||||||
| Series 1 | ||||||||||||||||||||
| Series 3 | ||||||||||||||||||||
| Series 4 | ||||||||||||||||||||
| Series 5 | ||||||||||||||||||||
Loading...